« Back to Record
Citation APA

Hadji, P., Santini, D., Diel, I. J., Di Leo, A., Cameron, D. A., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thürlimann, B., Coleman, R., Untch, M., Cortes, J., Martin, M., Albert, U. S., Conte, P. F. R. P., Ejlertsen, B., Bergh, J., Kaufman, M., Holen, I., Wilson, C., Powles, T. J., Clezardin, P., Aapro, M., Costa, L., Body, J.-J., & Markopoulos, C. (2016). Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel. Annals of oncology, 27(3), mdv617, 379-390. doi:10.1093/annonc/mdv617


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231140

Hadji, P., Santini, D., Diel, I. J., Di Leo, A., Cameron, D. A., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thürlimann, B., Coleman, R., Untch, M., Cortes, J., Martin, M., Albert, U. S., Conte, P. F. R. P., Ejlertsen, B., Bergh, J., Kaufman, M., Holen, I., Wilson, C., Powles, T. J., Clezardin, P., Aapro, M., Costa, L., Body, J.-J., & Markopoulos, C. (2016). Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel. Annals of oncology, 27(3), mdv617, 379-390. doi:10.1093/annonc/mdv617